Vioxx

JAMA duped by ghostwritten paper about VIOXX

admin_huliq — Wed, 16 Apr 2008 15:50:19 -0500

JAMA's editor, Catherine D. DeAngelis, said her journal had been duped by a ghostwritten manuscript in 2002 that compared Vioxx with two competitors' drugs for knee pain, and she acknowledged that editors bore some responsibility, writes Philly Inquirer's Kari Stark.

Vioxx Studies: Ghostwriters And Merck Sponsorship

admin_huliq — Tue, 15 Apr 2008 16:31:15 -0500

While you thought that those Vioxx studies in medical journals were independent, hands-off affairs that may not have been necessarily true. An examination of medical journal articles about Vioxx and court documents from Vioxx lawsuits found that Merck employees or ghostwriters were frequently involved in various articles, but the primary authors were often academics who actually had little to do with the studies or didn’t always disclose financial ties to Merck.

Vioxx Settlement To Cost Merck $4.85 Billion

admin_huliq — Fri, 09 Nov 2007 09:06:55 -0600

Merck Agreement Provides for $4.85 Billion Vioxx Settlement Payment.

New study may explain Vioxx side-effects

harminka — Mon, 27 Aug 2007 12:40:24 -0500

Vioxx and related pain medications were taken off the market in 2004 because they caused dangerous heart problems in some people. A group of scientists, led by Timothy Hla at the University of Connecticut, may now have figured out how these drugs trigger these life-threatening side-effects.

New approach to restore faith in pharmaceutical industry

harminka — Fri, 19 Jan 2007 09:15:32 -0600